"Integrating AI into cardiac diagnostics has long shown immense promise, and Qure.ai’s latest advancement with qXR-CTR is a testament to how much of that potential is now being realized. Early detection of heart failure is a challenge, but with tools like these, we are narrowing the gap. The combination of identifying increased cardiothoracic ratio and pleural effusion, in particular, is a significant stride. I believe this amplifies the crucial role AI-driven solutions play in supporting cardiologists and enhancing patient outcomes. I look forward to seeing how technologies such as this one will further evolve the landscape of cardiac care.” - Dr. Tariq Ahmad, Chief, Heart Failure Program - Section of Cardiology, Yale School of Medicine
With the FDA clearance of qXR-CTR, Qure.ai continues to pave the way for advancements in medical imaging and diagnostic accuracy. This achievement brings us one step closer to a future where AI-driven technology revolutionizes patient care and augments radiology and clinical outcomes.
Ad Statistics
Times Displayed: 21280
Times Visited: 416 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About Qure.ai
Qure.ai is a leading health tech company that employs deep learning and AI tools to address the pressing challenges of modern healthcare. The company's innovative approach allows radiologists to focus their expertise where it matters most, providing instantaneous evaluation of medical scans to prioritize actionable patient cases.
Back to HCB News
